Hematology & Oncology

Immunotherapy Enhances Outcomes for University of Minnesota Health Patients with Hematologic Malignancies

Patients with relapsed and refractory leukemia and lymphoma currently have few curative options. Through a combination of leading-edge scientific research, clinical trials and advanced patient care, cancer specialists at the University of Minnesota Health Cancer Care are transforming management strategies for refractory disease.

What’s New in Minnesota Health Care?

Children’s Minnesota Names Marc Gorelick, MD, as Next President and Chief Operating Officer

Children’s Minnesota is pleased to welcome Marc Gorelick, MD, as its new President and Chief Operating Officer. Dr. Gorelick, who is Chief Operating Officer and Executive Vice President of Children’s...